CXCL12 and neoplasm: A survival study was conducted whereincontrol GFP or experimental CXCL12-secreting cellswere injected directly under the pancreatic capsule and tumor progression tracked using bioluminescence imaging.Overall, mice injected with CXCL12-expressing cells were found to have a significantly increased survival advantage compared to control mice (Fig.10A).While control mice had significanttumor burden by day 141, the majority of mice implanted with CXCL12-expressing PDACremainedalive, with little to no apparent tumor.